Abstract
fourth-generation cephalosporins (4GC) and 16 Gram-negative isolates susceptible to these classes of cephalosporins were studied. The bacterial identification and antibiotics sensitivity was performed by automated systems. Isolates were further characterized for CTX M geno-groups and types by multiplex PCR, monoplex PCR and sequencing of the representative isolates. Result: The majority of the isolates were found to be multiple-drug resistant showing concomitant resistance of cephalosporins with other classes, such as fluoroquinolones and aminoglycosides. However, this collection of bacterial isolates was persistently sensitive to carbapenems such as imipenem and meropenem. In addition, few isolates demonstrated resistance to tigecycline. Sixty-three isolates were studied; 47 (74.6%) showed resistance to 3GC and/or 4GC. Multiplex PCR demonstrated the presence of blaCTX M in 45 (95.7%) isolates. Further confirmation with multiplex and monoplex PCR revealed 41 (91.1%) and 4 (8.9%) bacterial isolates harboring blaCTX M Geno-group 1 and blaCTX M Geno-group 9, respectively. Out of 16 3GC/4GC sensitive isolates, 3 (18.8%) had CTX M genes, all were Geno-group 1. Sequencing revealed the presence of CTX-M 15 type ESBL from Geno-group 1 positive isolates; however, Group 9 isolates did not reveal any CTX-M type, rather they were non-specific amplifications. Conclusion: Bahraini G-ve bacterial population demonstrated multi-drug resistance to antibiotics. CTX M 15 type of ESBL is prevalent in Bahrain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.